FDA Alert Confirms Heart and Cancer Risks With Tofacitinib ...Middle East

Medscape - News
The FDA has alerted the public to an increased risk of serious heart-related problems and cancer risk associated with the Janus kinase inhibitor tofacitinib (Xeljanz, Xeljanz XR). News Alerts

Hence then, the article about fda alert confirms heart and cancer risks with tofacitinib was published today ( ) and is available on Medscape ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( FDA Alert Confirms Heart and Cancer Risks With Tofacitinib )

Apple Storegoogle play

Last updated :

Also on site :